Krystal Biotech, Inc. · NASDAQ:KRYS

Krishnan Suma sold 25,000 Krystal Biotech, Inc. shares (Form 4)

Traded Jun 4, 2026 · Filed Jun 5, 2026

On Jun 4, 2026, Krishnan Suma (Director, President, R&D, 10% owner) sold 25,000 Krystal Biotech, Inc. shares at an average US$308.12 for US$7.7M under a trading plan, leaving 1,378,155 shares. Filed Jun 5, 2026 (Form 4).

Sold
25,000 shares
Price
US$308.12 average (US$300.75 to US$311.65)
Value
US$7.7M
Holding after
1,378,155 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President, R&D, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 4, 2026Common StockSale320US$300.751,402,835Direct
Jun 4, 2026Common StockSale593US$302.251,402,242Direct
Jun 4, 2026Common StockSale247US$303.171,401,995Direct
Jun 4, 2026Common StockSale400US$304.891,401,595Direct
Jun 4, 2026Common StockSale480US$305.871,401,115Direct
Jun 4, 2026Common StockSale1,348US$307.091,399,767Direct
Jun 4, 2026Common StockSale12,729US$307.811,387,038Direct
Jun 4, 2026Common StockSale3,803US$308.891,383,235Direct
Jun 4, 2026Common StockSale2,801US$309.951,380,434Direct
Jun 4, 2026Common StockSale2,039US$310.941,378,395Direct
Jun 4, 2026Common StockSale240US$311.651,378,155Direct

Source

View original at SEC

Related